Alboushi, L.* ; Hackett, A.P.* ; Naeli, P.* ; Bakhti, M. ; Jafarnejad, S.M.*
Multifaceted control of mRNA translation machinery in cancer.
Cell. Signal. 84:110037 (2021)
The mRNA translation machinery is tightly regulated through several, at times overlapping, mechanisms that modulate its efficiency and accuracy. Due to their fast rate of growth and metabolism, cancer cells require an excessive amount of mRNA translation and protein synthesis. However, unfavorable conditions, such as hypoxia, amino acid starvation, and oxidative stress, which are abundant in cancer, as well as many anti-cancer treatments inhibit mRNA translation. Cancer cells adapt to the various internal and environmental stresses by employing specialised transcript-specific translation to survive and gain a proliferative advantage. We will highlight the major signaling pathways and mechanisms of translation that regulate the global or mRNA-specific translation in response to the intra- or extra-cellular signals and stresses that are key components in the process of tumourigenesis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cancer ; Elongation ; Initiation ; Mrna Translation ; Protein Synthesis ; Ribosome Recycling ; Signaling Pathway ; Stress ; Termination ; Translation Machinery ; Tumourigenesis; Internal-ribosome-entry; Initiation-factor 4e; Cap-binding Protein; Elongation-factor 2; La-related Protein-1; P70 S6 Kinase; Factor 4e-binding Protein-1; Integrated Stress-response; To-mesenchymal Transition; Ires-mediated Translation
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
0898-6568
e-ISSN
0898-6568
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 84,
Issue: ,
Pages: ,
Article Number: 110037
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Ste 800, 230 Park Ave, New York, Ny 10169 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502300-001
Grants
New Frontiers in Research Fund-Exploration (Canada)
Medical Research Council, United Kingdom (MRC)
Copyright
Erfassungsdatum
2021-06-29